Testing firms are (again) back in favour
08/09/21 -"With the rise in Delta variant cases/risks in different parts of the world – especially in the US and Europe, testing firms are likely to witness re-emerging tailwinds. This has already begun ..."
Pages
76
Language
English
Published on
08/09/21
You may also be interested by these reports :
05/10/26
When we last teased on Fresenius (BUY; Germany) in May 2025, the story was about slimming down: shedding Vamed, deconsolidating FMC and working the ...
03/10/26
In addition to our upward revision of estimates (as discussed in the EPS section), the strong momentum in the hearing aids sector, the rebound in ...
28/09/26
Along with the downgrades to our DCF and NAV, we now apply a 10% discount to our peer-based valuation metrics. This reflects S&N’s growth lagging ...
14/09/26
Equity markets ended lower on the week ending September 11 as the renewed surge in energy prices revived inflation concerns and pushed bond yields ...